Last reviewed · How we verify
NCT03353181: ENBD
Application of Endoscopic Scissors Cutting ENBD Tube in the Treatment of Malignant Hilar Biliary Strictures
NA trial testing Endoscopic scissors in Endoscopic Retrograde Cholangiopancreatography. Withdrawn.
25 September 2019
Quick facts
| Lead sponsor | Changhai Hospital |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Start date | 30 November 2017 |
| Primary completion | 25 September 2019 |
| Estimated completion | 25 December 2019 |
| Sites | 1 location across China |
Drugs / interventions tested
- Endoscopic scissors
- Biliary stent
Conditions studied
- Endoscopic Retrograde Cholangiopancreatography — all drugs for Endoscopic Retrograde Cholangiopancreatography →
- Klatskin Tumor — all drugs for Klatskin Tumor →
Sponsor
Changhai Hospital
Who can join
18 and older, any sex, with Endoscopic Retrograde Cholangiopancreatography or Klatskin Tumor. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate application value of the endoscopic cutting technique in the treatment of malignant hilar biliary strictures.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03353181
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Endoscopic Retrograde Cholangiopancreatography
Currently open trials in the same condition.
- NCT07440342 — TEAS for Sedation During ERCP: A Multicenter Trial · NA · recruiting
- NCT06716541 — Biodegradable Stents in Liver Transplant RecipIents for Treatment of Biliary Anastomotic Strictures · NA · recruiting
- NCT06776874 — Observational Study to Develop a Predictive Score for Adverse Events Post ERCP · recruiting
- NCT04408482 — Does Pancreatic Stent Decrease the Risk of Pancreatitis After Pancreatic Sphincterotomy for Difficult Cannulation? · NA · recruiting
Other Changhai Hospital trials
Trials by the same sponsor.
- NCT07490002 — Neoadjuvant Therapy With Iparomlimab and Tuvonralimab, Lenvatinib and Chemotherapy in Resectable ESCC · Phase 2 · not yet recruiting
- NCT07464392 — FMT for the Prevention of Infectious Complications in Patients With Moderately Severe and Severe Acute Pancreatitis · NA · recruiting
- NCT07507071 — Comparison of the Sensitivity of pCLE and Pathological Biopsy for Gastric Mucosal Lesions · not yet recruiting
- NCT07481591 — Capsule Endoscopy in GI Bleeding: A Retrospective Study · not yet recruiting
- NCT07439757 — AI-Powered Precision Decision-Making for Pancreatic Diseases · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03353181 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Changhai Hospital
- Last refreshed: 25 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03353181.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing